✨ 2 results found - Searched 21220 records in 2ms.
Tesis
Efikasi dan Toksisiti Erlotinib/Gefitinib sebagai Terapi Lini Kedua Pada Pasien Kanker Paru Jenis Karsinoma Bukan Sel Kecil
2015 | BY Sita Laksmi Andarini - Jamaluddin M. - Achmad Hudoyo- Efficacy and Toxicity Erlotinib/Gefitinib as Second Line Therapy in Non-Small Cell Lung Cancer Patients.
- Nomor Panggil T 15 543 FK
Tesis
Peran quiescent lung cancer stem cell (CSC) dalam proses resistans terhadap agen epidermal growth factor receptortyrosine kinase inhibitor (EGFR-TKI) pada adenokarsinoma paru dengan mutasi EGFR positif
2020 | BY Moulid Hidayat - Sita Laksmi Andarini - Fumiyuki Takahashi- Role of quiescent lung cancer stem cells in epidermal growth factor receptor-tyrosine kinase inhibitor (EGFR- TKI) resistance in EGFR-mutant lung adenocarcinoma.
- Nomor Panggil T20481fk